Publikationen

75.

Thiele S, Ziegler N, Tsourdi E, Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2012; 27(11):2242—2250.      [DOI] 

74.

Thiele S, Ziegler N, Tsourdi E, Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2012; 27(11):2242—2250.      [DOI] 

73.

Thiele S, Ziegler N, Tsourdi E, Bosscher K, Tuckermann JP, Hofbauer LC, Rauner M. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2012; 27(11):2242—2250.      [DOI] 

72.

Rauch A, Gossye V, Bracke D, Gevaert E, Jacques P, Beneden K, Vandooren B, Rauner M, Hofbauer LC, Haegeman G, Elewaut D, Tuckermann JP, Bosscher K. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2011; 25(4):1323—1332.      [DOI] 

71.

Rauch A, Gossye V, Bracke D, Gevaert E, Jacques P, Beneden K, Vandooren B, Rauner M, Hofbauer LC, Haegeman G, Elewaut D, Tuckermann JP, Bosscher K. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2011; 25(4):1323—1332.      [DOI] 

70.

Rauch A, Gossye V, Bracke D, Gevaert E, Jacques P, Beneden K, Vandooren B, Rauner M, Hofbauer LC, Haegeman G, Elewaut D, Tuckermann JP, Bosscher K. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2011; 25(4):1323—1332.      [DOI] 

69.

Luther J, Driessler F, Megges M, Hess A, Herbort B, Mandic V, Zaiss MM, Reichardt A, Zech C, Tuckermann JP, Calkhoven CF, Wagner EF, Schett G, David J. Elevated Fra-1 expression causes severe lipodystrophy. Journal of cell science. 2011; 124(Pt 9):1465—1476.      [DOI] 

68.

Luther J, Driessler F, Megges M, Hess A, Herbort B, Mandic V, Zaiss MM, Reichardt A, Zech C, Tuckermann JP, Calkhoven CF, Wagner EF, Schett G, David J. Elevated Fra-1 expression causes severe lipodystrophy. Journal of cell science. 2011; 124(Pt 9):1465—1476.      [DOI] 

67.

Luther J, Driessler F, Megges M, Hess A, Herbort B, Mandic V, Zaiss MM, Reichardt A, Zech C, Tuckermann JP, Calkhoven CF, Wagner EF, Schett G, David J. Elevated Fra-1 expression causes severe lipodystrophy. Journal of cell science. 2011; 124(Pt 9):1465—1476.      [DOI] 

66.

Baschant U, Frappart L, Rauchhaus U, Bruns L, Reichardt HM, Kamradt T, Bräuer R, Tuckermann JP. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(48):19317—19322.      [DOI] 

65.

Baschant U, Frappart L, Rauchhaus U, Bruns L, Reichardt HM, Kamradt T, Bräuer R, Tuckermann JP. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(48):19317—19322.      [DOI] 

64.

Baschant U, Frappart L, Rauchhaus U, Bruns L, Reichardt HM, Kamradt T, Bräuer R, Tuckermann JP. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(48):19317—19322.      [DOI] 

63.

Schweingruber N, Haine A, Tiede K, Karabinskaya A, Brandt J, Wüst S, Metselaar JM, Gold R, Tuckermann JP, Reichardt HM, Lühder F. Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(8):4310—4318.      [DOI] 

62.

Schweingruber N, Haine A, Tiede K, Karabinskaya A, Brandt J, Wüst S, Metselaar JM, Gold R, Tuckermann JP, Reichardt HM, Lühder F. Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(8):4310—4318.      [DOI] 

61.

Schweingruber N, Haine A, Tiede K, Karabinskaya A, Brandt J, Wüst S, Metselaar JM, Gold R, Tuckermann JP, Reichardt HM, Lühder F. Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(8):4310—4318.      [DOI] 

60.

Rose AJ, Berriel Díaz M, Reimann A, Klement J, Walcher T, Krones-Herzig A, Strobel O, Werner J, Peters A, Kleyman A, Tuckermann JP, Vegiopoulos A, Herzig S. Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell metabolism. 2011; 14(1):123—130.      [DOI] 

59.

Rose AJ, Berriel Díaz M, Reimann A, Klement J, Walcher T, Krones-Herzig A, Strobel O, Werner J, Peters A, Kleyman A, Tuckermann JP, Vegiopoulos A, Herzig S. Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell metabolism. 2011; 14(1):123—130.      [DOI] 

58.

Rose AJ, Berriel Díaz M, Reimann A, Klement J, Walcher T, Krones-Herzig A, Strobel O, Werner J, Peters A, Kleyman A, Tuckermann JP, Vegiopoulos A, Herzig S. Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell metabolism. 2011; 14(1):123—130.      [DOI] 

57.

Schmieder A, Schledzewski K, Michel J, Tuckermann JP, Tome L, Sticht C, Gkaniatsou C, Nicolay JP, Demory A, Faulhaber J, Kzhyshkowska J, Géraud C, Goerdt S. Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A. International journal of cancer. 2011; 129(1):122—132.      [DOI] 

56.

Schmieder A, Schledzewski K, Michel J, Tuckermann JP, Tome L, Sticht C, Gkaniatsou C, Nicolay JP, Demory A, Faulhaber J, Kzhyshkowska J, Géraud C, Goerdt S. Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A. International journal of cancer. 2011; 129(1):122—132.      [DOI] 

55.

Schmieder A, Schledzewski K, Michel J, Tuckermann JP, Tome L, Sticht C, Gkaniatsou C, Nicolay JP, Demory A, Faulhaber J, Kzhyshkowska J, Géraud C, Goerdt S. Synergistic activation by p38MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4A8A. International journal of cancer. 2011; 129(1):122—132.      [DOI] 

54.

Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, Stolte J, Sparla R, D'Alessandro LA, Klingmüller U, Fleming RE, Longerich T, Gröne HJ, Benes V, Kauppinen S, Hentze MW, Muckenthaler MU. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. The Journal of clinical investigation. 2011; 121(4):1386—1396.      [DOI] 

53.

Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, Stolte J, Sparla R, D'Alessandro LA, Klingmüller U, Fleming RE, Longerich T, Gröne HJ, Benes V, Kauppinen S, Hentze MW, Muckenthaler MU. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. The Journal of clinical investigation. 2011; 121(4):1386—1396.      [DOI] 

52.

Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David J, Reichardt HM, Amling M, Schütz G, Tuckermann JP. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell metabolism. 2010; 11(6):517—531.      [DOI] 

51.

Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt-Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David J, Reichardt HM, Amling M, Schütz G, Tuckermann JP. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell metabolism. 2010; 11(6):517—531.      [DOI]